Anxiety Disorders Completed Phase Trials for Lorazepam (DB00186)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00715039Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety DisorderBasic Science